Watanabe, Jun
Terazawa, Tetsuji
Yamane, Shiho
Kazama, Hirotaka
Uetake, Hiroyuki
Yoshino, Takayuki http://orcid.org/0000-0002-0489-4756
Funding for this research was provided by:
Sanofi
Article History
Received: 6 July 2022
Accepted: 19 October 2022
First Online: 28 October 2022
Declarations
:
: JW reports honoraria from Johnson & Johnson K.K., Medtronic Japan Co., Ltd. and Eli Lilly Japan K.K. outside the submitted work and research funding from Medtronic Japan Co., Ltd., AMCO Inc. and Terumo Corporation outside the submitted work. TT is an employee of Shionogi. Co., Ltd. and reports honoraria from Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Taiho Pharmaceutical Co. Ltd. and Sanofi. HU reports honoraria and research funding from Chugai Pharmaceutical Co., Ltd. SY and HK are employees and stockholders in Sanofi. TY reports honoraria from Taiho Pharmaceutical Co. Ltd., Chugai Pharmaceutical Co., Ltd., Eli Lilly Japan K.K., Merck Biopharma Co., Ltd., Bayer Yakuhin, Ltd., Ono Pharmaceutical Co., Ltd., and MSD K.K. and reports research funding from Ono Pharmaceutical Co., Ltd., Sanofi, Daiichi Sankyo Co., Ltd., Parexel International Inc., Pfizer Japan Inc., Taiho Pharmaceutical Co. Ltd., MSD K.K., Amgen K.K., Sysmex Corporation, and Nippon Boehringer Ingelheim Co., Ltd.